×

1 / 1

TGF β1 Recombinant Mouse Monoclonal Antibody

 -

一键复制产品信息

货号:
AWA00083
应用:
WB,IHC-P,IF-C,FCM,ELISA
反应性:
Human,Mouse,Rat
来源:
Mouse
  • 20μL
  • ¥620
  • 1-3个工作日
  • 50μL
  • ¥1250
  • 1-3个工作日
  • 100μL
  • ¥2200
  • 1-3个工作日
  • 产品概述
  • Product Details

    Host Species:

    Mouse

    Reactivity:

    Human, Mouse, Rat

    Molecular Wt:

    Predicted MW: 44 kDa
    Observed MW: 44-50 kDa

     

    Clonality:

    Monoclonal

    Isotype:

    IgG2a

    Concentration:

    1.084mg/ml

     

    Other Names:

    TGFB1; TGFB; Transforming growth factor beta-1; TGF-beta-1; TGF β1

     

    Formulation:

    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

     

    Purification:

    Affinity-chromatography

     

    Storage:

    Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20°C storage.

    Applications

    WB 1:1000-1:5000
    IHC-P 1:100-1:1000
    IF-C 1:50-1:500
    FCM 1:50-1:200
    ELISA 1:20000

    Immunogen
    Information

    Gene Name:

    TGFB1

    Protein Name:

    Transforming growth factor beta-1 proprotein

     

    Gene ID:

    7040 (Human)
    21803 (Mouse)
    59086 (Rat)

    SwissPro:

    P01137 (Human)
    P04202 (Mouse)
    P17246 (Rat)

    Immunogen
    Information

    Subcellular Location:

    Secreted, extracellular space, extracellular matrix. Secreted.

     

    Immunogen:

    Recombinant protein within human TGF β1.

     

    Specificity:

    TGF β1 Monoclonal Antibody detects endogenous levels of TGF β1 protein.


    Product images
    TGF β1 Recombinant Mouse Monoclonal Antibody - 1 Fig: Immunocytochemistry analysis of NIH3T3 cells labeling TGF β1 with Mouse anti-TGF β1 antibody (AWA00083) at 1/50 dilution(Green).
    Cells were fixed in 4% paraformaldehyde for 10 minutes at 37 ℃, permeabilized with 0.03% Triton X-100 in PBS for 30 minutes, and then blocked with 5% BSA for 60 minutes at 37 ℃. Cells were then incubated with Mouse anti-TGF β1 antibody (AWA00083) at 1/50 dilution in 2% negative goat serum overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, AWS0003) was used as the secondary antibody at 1/200 dilution for 60 minutes at 37 ℃. Nuclear DNA was labelled in blue with DAPI(AWC0291).
    TGF β1 Recombinant Mouse Monoclonal Antibody - 2 Fig : Immunohistochemical analysis of paraffin-embedded Mouse-lung tissue with Mouse anti- TGF β1 antibody (AWA00083) at 1/200 dilution.
    The section was pre-treated using heat mediated antigen retrieval with Sodium citrate buffer (pH 6.0) for 20 minutes. The tissues were blocked in 3% H2O2 for 15 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (AWA00083) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system(ABIOWELL, AWI0629). DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
    TGF β1 Recombinant Mouse Monoclonal Antibody - 3 Fig : Western blot analysis of TGF β1 on different lysates. Proteins were transferred to a NC membrane and blocked with 5% NF-Milk in TBST for 1 hour at room temperature. The primary antibody (AWA00083, 1/1000) was used in TBST at room temperature for 2 hours. Goat Anti-Mouse IgG - HRP Secondary Antibody (AWS0001) at 1:5,000 dilution was used for 1 hour at room temperature.
    Positive control:
    Lane 1: HepG2 cell
    Predicted molecular weight: 44 kDa
    Observed molecular weight: 44-50 kDa

    引用文献 (1)

    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY IF:2.2

    The progression of renal fibrosis is difficult to reverse, and Poria cocos, one of the main components of Wenyang Zhenshuai Granules, has been shown to be crucial to the development of the epithelial-mesenchymal transition (EMT). This study aimed to examine the molecular mechanism by which Poricoic Acid A (PAA) inhibited the advancement of EMT in renal tubular epithelial (RTE) cells. The protein levels of sprouty RTK signaling antagonist 2 (SPRY2) extracellular regulated protein kinases (ERK), and p-ERK were measured. The EMT progression of RTE cells was evaluated by a series of experiments. The regulatory relationship of PAA to SPRY2 was determined by cycloheximide, molecular docking and drug affinity target stability and immunoprecipitation. The overexpression of SPRY2 or PAA intervention suppressed the HK-2 and NRK-52E cell's viability, proliferation and migration ability of TGF-β1-induced while raising the levels of E-cadherin and decreasing those of collagen I, collagen III, Fibronectin1, α-SMA, Vimentin, ZEB1, Twist, Snail and Slug. PAA was able to be combined with SPRY2 protein. Besides, we found that PAA intervention increased the stability of SPRY2 through the ubiquitin-proteasome pathway, did not affect ERK levels, and reduced the levels of p-ERK. Finally, we found that inhibiting SPRY2 negated the beneficial effect of PAA on TGF-β1-stimulated RTE cells. PAA alleviated the EMT of RTE cells by modulating the SPRY2/ERK pathway.

    pubTime 2025-11-01
    Application
    WB
    Specie
    Dilution
    1:1000

    复制成功!

    内容已复制到剪贴板

    在线客服
    关闭
    小薇 薇薇 小艾 小奥
    联系销售
    技术支持

    image.png

    月琴艾碧维二维码.jpg